VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HQY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HQYHealthEquity, Inc.
$87.81$7.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHQYQuarterly Financials

HealthEquity, Inc. (HQY) Quarterly Financials

120+ quarters historyFree accessUpdated daily

HealthEquity, Inc. (HQY) quarterly income statement — complete revenue, gross profit & net income history

HQY Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24
Sales/Revenue354.64M334.59M322.16M325.83M330.84M311.82M300.43M299.93M287.6M262.39M249.22M243.55M
Revenue Growth %7.19%7.3%7.23%8.64%15.04%18.84%20.55%23.15%17.66%12.21%15.33%18.15%
Cost of Goods Sold98.33M25.43M121.1M120.24M133.53M122.58M131.76M126.86M126M122.28M114.02M115.78M
COGS % of Revenue27.73%7.6%37.59%36.9%40.36%39.31%43.86%42.3%43.81%46.6%45.75%47.54%
Gross Profit256.31M309.15M201.06M205.59M197.31M189.24M168.68M173.07M161.59M140.1M135.19M127.76M
Gross Margin %72.27%92.4%62.41%63.1%59.64%60.69%56.14%57.7%56.19%53.4%54.25%52.46%
Gross Profit Growth %29.9%63.36%19.2%18.79%22.1%35.07%24.77%35.46%29.63%26.12%30.85%36.45%
Operating Expenses153.36M241.78M121.21M114.72M112.96M117.71M114.61M112.36M117.82M98.94M101.65M100.98M
OpEx % of Revenue43.24%72.26%37.62%35.21%34.14%37.75%38.15%37.46%40.97%37.71%40.79%41.46%
Selling, General & Admin57.96M171.43M55.29M49.91M51.52M53.06M54.42M53.78M61.73M43.7M46.03M46.21M
SG&A % of Revenue16.34%51.24%17.16%15.32%15.57%17.02%18.12%17.93%21.46%16.65%18.47%18.97%
Research & Development67.77M70.35M65.92M64.8M61.44M64.65M60.19M58.58M56.09M55.24M55.61M54.77M
R&D % of Revenue19.11%21.03%20.46%19.89%18.57%20.73%20.03%19.53%19.5%21.05%22.32%22.49%
Other Operating Expenses1000K00000000000
Operating Income102.95M67.37M79.85M90.88M84.35M71.53M54.06M60.71M43.77M41.16M33.55M26.78M
Operating Margin %29.03%20.14%24.79%27.89%25.5%22.94%17.99%20.24%15.22%15.69%13.46%11%
Operating Income Growth %22.05%-5.81%47.71%49.7%92.71%73.76%61.16%126.65%64.32%124.63%178.37%408.14%
EBITDA115.58M-48.6M118.63M129.33M123.09M110.71M94.78M104.32M82.71M79.08M56.76M65.13M
EBITDA Margin %32.59%-14.53%36.82%39.69%37.21%35.5%31.55%34.78%28.76%30.14%22.77%26.74%
EBITDA Growth %-6.1%-143.9%25.16%23.98%48.82%40%66.99%60.17%25.93%34.48%8.01%41.55%
D&A (Non-Cash Add-back)12.63M-115.97M38.78M38.45M38.74M39.18M40.72M43.61M38.94M37.91M23.21M38.35M
EBIT93.33M62.06M81.58M93M85.81M45.22M24.37M62.04M45.03M43.36M34.63M27.5M
Net Interest Income-10.7M-10.12M-11.19M-11.59M-12.13M-12.22M-14.26M-12.32M-7.91M-9.3M-9.83M-10.79M
Interest Income1.89M3.15M2.86M3.36M2.73M3.03M3.9M3.1M3.88M4.34M3.71M2.48M
Interest Expense12.59M13.27M14.05M14.96M14.86M15.26M18.16M15.43M11.79M13.64M13.54M13.27M
Other Income/Expense-10.54M-6.47M-12.32M-12.83M-13.4M-41.57M-47.84M-14.09M-10.53M-11.45M-12.46M-12.56M
Pretax Income92.41M60.9M67.53M78.05M70.95M29.96M6.22M46.62M33.24M29.72M21.09M14.22M
Pretax Margin %26.06%18.2%20.96%23.95%21.45%9.61%2.07%15.54%11.56%11.33%8.46%5.84%
Income Tax23M11.16M15.84M18.19M17.04M3.6M515K10.79M4.43M3.35M6.41M3.64M
Effective Tax Rate %24.88%18.32%23.46%23.31%24.01%12%8.28%23.16%13.32%11.28%30.42%25.61%
Net Income69.42M49.74M51.69M59.85M53.91M26.36M5.7M35.82M28.81M26.36M14.67M10.58M
Net Margin %19.57%14.87%16.05%18.37%16.3%8.46%1.9%11.94%10.02%10.05%5.89%4.34%
Net Income Growth %28.75%88.66%806.4%67.09%87.12%0%-61.13%238.55%603.79%12714.35%994.15%199.31%
Net Income (Continuing)69.42M49.74M51.69M59.85M53.91M26.36M5.7M35.82M28.81M26.36M14.67M10.58M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)0.820.580.590.680.610.300.060.400.330.300.170.12
EPS Growth %34.43%93.33%817.57%70%84.85%0%-62.18%233.33%560%-976.29%192.31%
EPS (Basic)0.820.590.600.690.620.300.070.410.330.310.170.12
Diluted Shares Outstanding85.01M87.47M86.97M87.75M88.42M88.61M88.63M88.65M88.32M87.44M87.12M86.34M
Basic Shares Outstanding84.41M86.13M86M86.55M86.66M86.7M87.19M87.13M86.47M85.97M85.7M85.53M
Dividend Payout Ratio------------